CLINICAL_TRIALS
trial_result
· 2022-08-15
Clinical Trial Update: Canagliflozin-Mealtime Insulin Rescue [Phase 4]
Summary
Phase 4 trial update evaluating canagliflozin in combination with mealtime insulin for type 2 diabetes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Foundation for Atlanta Veterans Education and Research, Inc. | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: UNKNOWN